Ann M. Hanly - Net Worth and Insider Trading

Ann M. Hanly Net Worth

The estimated net worth of Ann M. Hanly is at least $1 Million dollars as of 2024-05-13. Ann M. Hanly is the EVP & Chief Technology Officer of Vir Biotechnology Inc and owns about 132,081 shares of Vir Biotechnology Inc (VIR) stock worth over $1 Million. Details can be seen in Ann M. Hanly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ann M. Hanly has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).

Transaction Summary of Ann M. Hanly

To

Ann M. Hanly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ann M. Hanly owns 1 companies in total, including Vir Biotechnology Inc (VIR) .

Click here to see the complete history of Ann M. Hanly’s form 4 insider trades.

Insider Ownership Summary of Ann M. Hanly

Ticker Comapny Transaction Date Type of Owner
VIR Vir Biotechnology Inc 2024-04-01 Chief Technology Officer

Ann M. Hanly Latest Holdings Summary

Ann M. Hanly currently owns a total of 1 stock. Ann M. Hanly owns 132,081 shares of Vir Biotechnology Inc (VIR) as of April 1, 2024, with a value of $1 Million.

Latest Holdings of Ann M. Hanly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VIR Vir Biotechnology Inc 2024-04-01 132,081 9.44 1,246,845

Holding Weightings of Ann M. Hanly


Ann M. Hanly Form 4 Trading Tracker

According to the SEC Form 4 filings, Ann M. Hanly has made a total of 6 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Vir Biotechnology Inc is the sale of 2,711 shares on April 1, 2024, which brought Ann M. Hanly around $27,246.

Insider Trading History of Ann M. Hanly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ann M. Hanly Trading Performance

GuruFocus tracks the stock performance after each of Ann M. Hanly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ann M. Hanly is -40.71%. GuruFocus also compares Ann M. Hanly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ann M. Hanly within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ann M. Hanly's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ann M. Hanly

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.38
Relative Return to S&P 500(%) -6.34

Ann M. Hanly Ownership Network

Ownership Network List of Ann M. Hanly

No Data

Ownership Network Relation of Ann M. Hanly


Ann M. Hanly Owned Company Details

What does Vir Biotechnology Inc do?

Who are the key executives at Vir Biotechnology Inc?

Ann M. Hanly is the Chief Technology Officer of Vir Biotechnology Inc. Other key executives at Vir Biotechnology Inc include Chief Executive Officer Backer Marianne De , Chief Financial Officer Sung Lee , and director & President and CEO George A Scangos .

Vir Biotechnology Inc (VIR) Insider Trades Summary

Over the past 18 months, Ann M. Hanly made 4 insider transaction in Vir Biotechnology Inc (VIR) with a net sale of 19,936. Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 4,932,420 shares made by Svf Endurance (cayman) Ltd , a net sale of 58,569 shares made by Phillip Pang , and a net sale of 89,680 shares made by Vicki L Sato .

In summary, during the past 3 months, insiders sold 167,399 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 167,399 shares. During the past 18 months, 5,306,538 shares of Vir Biotechnology Inc (VIR) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 5,299,038 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vir Biotechnology Inc Insider Transactions

No Available Data

Ann M. Hanly Mailing Address

Above is the net worth, insider trading, and ownership report for Ann M. Hanly. You might contact Ann M. Hanly via mailing address: C/o Vir Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco Ca 94158.

Discussions on Ann M. Hanly

No discussions yet.